| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086231A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1085909A2 Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 03/28/2001 | EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
| 03/27/2001 | US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies |
| 03/27/2001 | US6207804 Genetically engineered antibody analogues and fusion proteins thereof |
| 03/27/2001 | US6207418 Production of a multimeric protein by cell fusion method |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001019866A1 Dipeptidyl peptidases |
| 03/22/2001 | WO2001019846A1 Transgenically produced fusion proteins |
| 03/22/2001 | WO2001019842A1 Subunit optimized fusion proteins |
| 03/22/2001 | WO2001019408A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | WO2000060066A8 Protein-protein from s. cerevisiae and methods of using same |
| 03/22/2001 | WO2000020591A9 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | CA2384987A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | CA2384766A1 Subunit optimized fusion proteins |
| 03/22/2001 | CA2384135A1 Dipeptidyl peptidases |
| 03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
| 03/21/2001 | EP1085024A1 Peptides having nuclear transport activity |
| 03/21/2001 | EP1084242A2 Phagocytic assay method |
| 03/21/2001 | EP1084146A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204326 Adding peptide nucleic acid units to an amine terminated peptide nucleic acid oligomer on a solid phase synthetic resin; biosynthesis |
| 03/20/2001 | US6204246 Derived from bacillus thuringiensis insecticidal crystal proteins. |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6204011 Human receptor tyrosine kinase, KDR |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018050A2 T2r taste receptor family |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2384777A1 T2r taste receptor family |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/14/2001 | EP1082439A2 Recombinant narbonolide polyketide synthase |
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016318A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016178A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2645727A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481788A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481756A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481691A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481685A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2382989A1 Materials and methods for inhibition of ige production |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/06/2001 | US6197946 Nucleotide sequences coding hybrid albumin polypeptide; for production of heterologous polypeptide in hybrid animals |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/06/2001 | CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use |
| 03/01/2001 | WO2001014570A1 Activatable recombinant neurotoxins |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014539A2 Methods and compositions for the construction and use of fusion libraries |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000059535A3 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | WO1999036537A3 Fatty acid transport proteins |
| 03/01/2001 | CA2589418A1 Human ctla-4 antibodies and their uses |
| 03/01/2001 | CA2382483A1 Methods and compositions for the construction and use of fusion libraries |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2380457A1 Activatable recombinant neurotoxins |
| 02/28/2001 | EP1078072A1 New peptide fragments for protein purification |
| 02/28/2001 | EP1078060A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/28/2001 | EP1078007A2 Verotoxin b subunit for immunization |
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use |
| 02/28/2001 | EP0584284B1 Recombinant dna-derived cholera toxin subunit analogs |
| 02/28/2001 | EP0429611B1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/27/2001 | US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria |
| 02/27/2001 | US6194172 Cytokine designated lerk-6 |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194140 HCV NS3 protein fragments having helicase activity and improved solubility |
| 02/27/2001 | US6193966 Administering bispecific protein or peptide molecule, comprising a first binding determinate which binds to fc.alpha.receptor without being blocked by immunoglobulin a and second binding determinant which binds to target antigen |